Active ingredientAlmorexantCat. No. P-A088-001CAS 871224-64-5Family · Pharmaceutical analytical standards
Almorexant
A dual orexin receptor antagonist, blocking the neuropeptides that keep us awake: studied as a sleeping pill for chronic insomnia up to a phase III trial completed in 2009, its development was stopped in 2011. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It comes off orexin receptors very slowly: in laboratory tests on the OX2 receptor its dissociation half-life is about four hours, an almost 'sticky' binding that can prolong its action.
Go to the active ingredient →Active ingredientAlmorexantCat. No. P-A088-001CAS 871224-64-5
Isotopically labelledAlmorexant Isomer-13C-d3Cat. No. P-A088-002
Isotopically labelledAlmorexant-13C-d3Cat. No. P-A088-003
Isotopically labelledAlmorexant-d6Cat. No. P-A088-004CAS 1162658-33-4
ImpurityAlmorexant (alphaS,1S)-IsomerCat. No. P-A088-005CAS 2055114-67-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.